Shanghai MicroPort Endovascular MedTech Co., Ltd. (SHA:688016)

China flag China · Delayed Price · Currency is CNY
99.09
-0.30 (-0.30%)
Apr 29, 2026, 3:00 PM CST
19.17%
Market Cap 11.97B
Revenue (ttm) 1.35B
Net Income (ttm) 563.33M
Shares Out 120.84M
EPS (ttm) 4.65
PE Ratio 21.31
Forward PE 19.03
Dividend 2.30 (2.31%)
Ex-Dividend Date n/a
Volume 1,536,971
Average Volume 1,858,253
Open 99.12
Previous Close 99.39
Day's Range 98.22 - 99.95
52-Week Range 83.01 - 124.30
Beta 0.23
RSI 45.48
Earnings Date Mar 31, 2026

About SHA:688016

Shanghai MicroPort Endovascular MedTech Co., Ltd. engages in the research and development, manufacturing, sale, and services of aortic, peripheral vascular, and tumor intervention devices in China and internationally. The company offers Fontus, a branched stent graft system in surgical operation; CRONUS, a stent graft system in surgical operation; Hector, a multi-branch thoracic stent graft system; Cratos and Castor, a branched aortic stent graft system; Talos, a thoracic stent graft system; and Hercules, a thoracic stent graft system with low ... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2012
Employees 822
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688016
Full Company Profile

Financial Performance

In 2025, SHA:688016's revenue was 1.35 billion, an increase of 11.96% compared to the previous year's 1.21 billion. Earnings were 563.33 million, an increase of 12.19%.

Financial Statements

News

There is no news available yet.